Hirschsprung’s disease

Newborn Surgery, Second Edition

Volumn , Issue , 2003, Pages 513-534

  Puri, Prem ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057902514     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (196)

1. Kleinhaus S, Boley SJ, Sheran M et al. Hirschsprung’s disease: a survey of the surgical section of the American Academy of Pediatrics.J PediatrSurg 1979; 14:588-97.
2. Ikeda K, Goto S. Diagnosis and treatment of Hirschsprung’s disease in Japan. An analysis of 1628 patients. Ann Surg 1984; 199:400-5.
3. Ziegler MM, Ross AJ III, Bishop HC. Total intestinal aganglionosis: a new technique for prolonged survival. J Pediatr Surg 1987; 22:82-3.
4. Senyiiz OF, Danismend N, Erdogan E et al. Total intestinal aganglionisis with involvement of the stomach. Pediatr Surg Int 1988; 3:74-5.
5. Lopez Guiterrez JC, de Augustin JC, Murcia J et al. A case of total intestinal aganglionosis. 2 years of survival. Cir Pediatr 1991; 4:212-14.
6. Zerella JT, Ingebo KR. A 3-year survivor of near-total intestinal aganglionosis. J Pediatr Surg 1993; 28:1589-91.
7. Nemeth L, Yoneda A, Kader M et al. Three-dimensional morphology of gut innervation in total intestinal aganglionosis using whole-mount preparation. J Pediatr Surg 2001; 36:291-5.
8. Passarge E. The genetics of Hirschsprung’s disease. N Engl J Med 1967; 276:138-43.
9. Spouge D, Baird PA. Hirschsprung’s disease in large birth cohort. Teratology 1985; 32:171-7.
10. Orr JD, Scobie WG. Presentation and incidence of Hirschsprung’s disease. Br Med J1983; 287:1671.
11. Sherman JO, Snyder ME, Weizman JJ et al. A 40 year multinational retrospective study of 880 Swenson’s procedures. J Pediatr Surg 1989; 24:833-8.
12. Okamoto E, Ueda T. Embryogenesis of intramural ganglia of the gut and its relation to Hirschsprung’s disease. J Pediatr Surg 1967; 2:437-43.
13. Gershon MD, Erde SM. The nervous system of the gut. Gastroenterology 1981; 80:1571-94.
14. Gershon MD, Chalazonitis A, Rothman TP. From neural crest to bowel: Development of the enteric nervous system. J Neurobiol 1993; 24:199-214.
15. Powely TL. Vagal input to the enteric nervous system. Gut 2000; 47 (Suppl IV): iv 3-32.
16. Goyal RK, Hirano I. The enteric nervous system. NEnglJ Med 1996; 334:1106-15.
17. Gershon MD. The enteric nervous system: A second brain. Hosp Pract (Off Ed) 1999; 31-2, 34, 35-38, 41-2.
18. Yntma CL, Hammond WS. The origin of intrinsic ganglia of trunk viscera from vagal neural crest in the chick embryo. J Comp Neurol 1954; 101:515-34.
19. Puri P, Ohshiro K, Wester T. Hirschsprung’s disease: A search for etiology. Semin Pediatr Surg 1998; 7:140-7.
20. Le Douarin NM, Teillet MA. The migration of neural crest cells to the wall of the digestive tract in avian embryo. J Embryol Exp Morph 1973; 30:31-48.
21. Le Douarin NM, Dupin E, Ziller C. Genetic and epigenetic controls in neural crest development. Curr Opin Genet Dev 1994; 4:685-95.
22. Pomeranz HD, Gershon MD. Colonization of the avian hindgut by cells derived from the sacral neural crest. Dev Biol 1990; 137:378-94.
23. Burns AJ, Douarin NM. The sacral neural crest contributes neurons and glia to the postumbilical gut: Spatiotemporal analysis of the development of the enteric nervous system. Development 1998; 125:4335-7.
24. Young HM, Hearn CJ, Newgreen DF. Embryology and development of enteric nervous system. Gut 2000; 47(Suppl IV): iv12-14.
25. Allan IJ, Newgreen DF. The origin and differentiation of enteric neurons of the intestine of the fowl embryo. Am J Anat 1980; 157:137-54.
26. Meijers JHC, Tibboel D, Van der Kamp AWM et al. A model for aganglionosis in the chicken embryo. J Pediatr Surg 1989; 24:557-61.
27. Fujimoto T, Hata J, Yokoyama S et al. A study of the extracellular matrix protein as the migration pathway of neural crest cells in the gut: Analysis in human embryos with special reference to the pathogenesis of Hirschsprung’s disease. J Pediatr Surg 1989; 24:550-6.
28. Meijers JHC, Tibboel D, Van der Kamp AWM et al. A model for aganglionosis in the chick embryo. J Pediatr Surg 1989; 24:557-61.
29. Fujimoto T, Hata J, Yokoyama S et al. A study of the extracellular matrix protein as the migration pathway of neural crest cells in the gut: Analysis in human embryos with special reference to the pathogenesis of Hirschsprung’s disease. J Pediatr Surg 1989; 24:550-6.
30. Bernfield M, Banerje S, Koda J et al. Remodeling of basement membrane as a mechanism of morphologenetic tissue interaction. In: Trelstadt E. editor. The Role of Extracellular Matrix in Development. New York: Liss, 1984: 545-72.
31. Greenberg JH, Seppa S, Seppa H et al. Role of collagen and fibronectin in neural crest cell adhesion and migration. Dev Bio 1981; 87:259-66.
32. Brauer PR, Markwald RR. Attachment of neural crest cells to endogenous extracellular matrices. Anat Rec 1987; 219:275-85.
33. Rothman TP, Le Douarin NM, Fontanine-Perus JC et al. Developmental potential of neural crest-derived cells migrating from segments of developing quail bowel back-grafted into younger chick host embryos. Development 1990; 109:411-23.
34. Rothman TP, Le Douarin NM, Fontanie-Perus JC et al. Colonization of the bowel by neural crest-derived cells re-migrating from foregut backtransplanted to vagal or sacral regions of host embryos. Dev Dynamics 1993; 196:217-33.
35. Parikh DH, Tam PKH, Van Velzen D et al. Abnormalities in the distribution of laminin and collagen type IV in Hirschsprung’s disease. Gastroenterol 1992; 102:1236-41.
36. Parikh DH, Tam PKH, Van Velzen D et al. The extracellular matrix components, tenascin and fibronectin in Hirschsprung’s disease: An immunohistochemical study. J Pediatr Surg 1994; 29:1302-6.
37. Thoenen H. The changing scene of neurotrophic factor. Trends Neurosci 1991; 14:165-70.
38. Kuroda T, Hirabayashi T, Fuchimoto Y. The localization of nerve growth factor in intestines of normal rats and megacolonic mice. J Smooth Muscle Res 1991; 27:401-2.
39. Kuroda T, Ueda M, Kitajima M et al. The expression of nerve growth factor mRNA in rat intestines. J Smooth Muscle Res 1992; 28:382-4.
40. Chalazonitis A, Rothman TP, Chen JX et al. Neurotrophin-3 induces neural crest-derived cells from fetal rat gut to develop in vitro as neurons or glia. J Neurosci 1994; 14:6571-84.
41. Thoenen H, Edgar D. Neurotrophic factors. Science 1985; 229:238-42.
42. Ohshiro K, Puri P. Decreased levels of nerve growth factor and neurotrophin-3 in the smooth muscle of Hirschsprung’s disease. Presented at the 10th International Symposium on Pediatric Surgical Research, Zurich, Switzerland, October 1997.
43. Ohshiro K, Puri P. Reduced glial cell-derived neurotrophic factor level in aganglionic bowel in Hirschsprung’s disease. J Pediatr Surg 1998; 33:904-8.
44. Crossin KL, Friedlander DR, Jones FS et al. Expression of adhesion molecules and the establishment of boundaries during embryonic and neural development. Exp Neurol 1990; 109:6-18.
45. Tosney KW, Watanable M, Landmesser L et al. The distribution of NCAM in the chick hind limb during axon outgrowth and synaptogenesis. Biol Dev 1986; 114:437-52.
46. Covault J, Sanea JR. Distribution of N-CAM in synaptic and extrasynaptic portions of developing and adult skeletal muscle. J Cell Biol 1986; 102:716-30.
47. Gordon L, Wharton J, Moore SE et al. Myocardial localization and isoforms of neural cell adhesion molecule (N-CAM) in the developing and transplanted human heart. J Clin Invest 1990; 86:1293-1330.
48. Rieger F, Grumet M, Edelman GM. N-CAM at the vertebrate neuromuscular junction. J Cell Biol 1985; 1-1:285-93.
49. Romanska HM, Bishop AE, Brereton RJ et al. Increased expression of muscular neural cell adhesion molecule in congenital aganglionosis. Gastrenterol 1993; 105:1104-09.
50. Kobayashi H, O’Briain DS, Puri P. 1994 Lack of expression of NADPH-diaphorase and neural cell adhesion molecule (NCAM) in colonic muscle of patients with Hirschsprung’s disease. J Pediatr Surg 1993; 29:301-4.
51. Ikawa H, Kawano H, Takeda Y et al. Impaired expression of neural cell adhesion molecule L1 in the extrinsic nerve fibers in Hirschsprung’s disease. J Pediatr Surg 1997; 32:542-5.
52. Kuroda T, Doody DP, Donahoe PK. Aberrant colonic expression of MHC class II antigens in Hirschsprung’s disease. Aust NZJ Surg 1991; 61:373-9.
53. Hirobe S, Doody DP, Ryan DP et al. Ectopic class II major histocompatibility antigens in Hirschsprung’s disease and neuronal intestinal dysplasia. J Pediatr Surg 1992; 27:357-62.
54. Kobayashi H, Hirakawa H, Puri P. Overexpression of intercellular adhesion molecule-1 (ICAM-1) and MHC class II antigen on Hirschsprung’s disease. J Pediatr Surg 1995; 30:1680-3.
55. Puri P. Hirschsprung’s disease. In: Oldham TO, Colombani PM, Foglia RP, editors. Surgery of Infants and Children: Scientific Principles and Practice. New York: Lippincott-Raven, 1997:1277-99.
56. Caniano DA, Ormsbee HS III, Polito W. Total intestinal aganglionosis. J Pediatr Surg 1985; 20:456-60.
57. Schiller M, Levy P, Shawa RA et al. Familial Hirschsprung’s disease - A report of 22 affected siblings in four families. J Pediatr Surg 1990; 25:322-5.
58. Engum SA, Petrites M, Rescorla FJ et al. Familial Hirschsprung’s disease: 20 cases in 12 kindreds. J Pediatr Surg 1993; 28:1286-9.
59. Goldberg E. An epidemiological study of Hirschsprung’s disease. Int J Epidemiol 1985; 13:479-85.
60. Caniano DA, Teitelbaum DH, Qualman SJ. Management of Hirschsprung’s disease in children with trisomy 21. Am J Surg 1990; 159:402-4.
61. Quinn FMJ, Surane R, Puri P. The influence of Trisomy 21 on outcome in children with Hirschsprung’s disease. J Pediatr Surg 1994; 29:781-3.
62. Badner JA, Seiber WK, Garver KL et al. A genetic study of Hirschsprung’s disease. Am J Hum Genet 1990; 46:568-80.
63. Montgomery RK, Mulberg AE, Grand RJ. Development of the human gastrointestinal tract: Twenty years of progress. Gastroenterology 1999; 116:702-31.
64. Taraviras S, Pachnis V. Development of the mammalian enteric nervous system. Curr Opin Gen Dev 1999; 9:321-7.
65. Schuchardt A, D’Agati V, Larsson-Blomberg L et al. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor. Ret Nature 1994; 367:380-3.
66. Luo Y, Cecchernin I, Pasini B et al. Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung’s disease. Hum Mol Genet 1993; 2:1803-8.
67. Romeo G, Ronchetto P, Luo Y et al. Point mutations affecting the tyrosine kinase domain of the RET protooncogene in Hirschsprung’s disease. Nature 1994; 367:377-8.
68. Edery P, Lyonnet S, Mulligan LM et al. Mutations of the RET proto-oncogene in Hirschsprung’s disease. Nature 1994; 367:378-80.
69. Kusafuka T, Puri P. Altered RET gene mRNA expression in Hirschsprung’s disease. J Pediatr Surg 1997; 32:600-4.
70. Kusafuka T, Puri P. The RET proto-oncogene: A challenge to understanding of disease pathogenesis. Pediatr Surg Int 1997; 12:11-18.
71. Martucciello G, Checcherini I, Lerone M et al. Pathogenesis of Hirschsprung’s disease. J Pediatr Surg 2000; 35:1017-25.
72. Edery P, Pelet P, Mulligan LM et al. Long segment and short segment familial Hirschsprung’s disease: Variable clinical expression at the RET locus. J Med Genet 1994; 31:602-6.
73. Seri M, Yin L, Barone V et al. Frequency of RET mutations in long- and short-segment Hirschsprung’s disease. Hum Mutat 1997; 9:243-9.
74. Hofstra RM, Landsvater RM, Ceccherini I et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994; 367:375-6.
75. Kusafuka T, Puri P. Genetic aspects of Hirschsprung’s disease. Semin Pediatr Surg 1998; 7:148-55.
76. Hellmich HL, Kos L, Cho ES et al. Embryonic expression of glial-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions. Mech Dev 1996; 54:95-105.
77. Worley DS, Pisano JM, Choi ED et al. Developmental regulation of GDNF response and receptor expression in the enteric nervous system. Development 2000; 127:4383-93.
78. Focke PJ, Schiltz CA, Jones SE et al. Enteric neuroblasts require the phosphatidylinositol 3-kinase pathway for GDNF-stimulated proliferation. J Neurobiol 2001; 47:306-17.
79. Young HM, Hearn CJ, Farlie PG et al. GDNF is a chemoattractant for enteric cells. Dev Biol 2001; 229:503-16.
80. Durbec P, Marcos-Gutierrez CV, Kilkenny C et al. GDNF signalling through the ret receptor tyrosine kinase. Nature 1996; 381:789-93.
81. Sanches M, Silos-Santiago I, Frisen J et al. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 1996; 382:70-3.
82. Pichel JG, Shen L, Sheng HZ et al. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 1996; 382:73-6.
83. Angrist M, Bolk S, Halushka M et al. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in Hirschsprung’s disease patient. Nat Genet 1996; 14:341-4.
84. Baynash AG, Hosoda K, Giaid A et al. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 1994; 79:1277-85.
85. Leibl MA, Ota T, Woodward MN et al. Expression of endothelin-3 by mesenchymal cells of embryonic mouse caecum. Gut 1999; 44:246-52.
86. Hosoda K, Hammer RE, Richardson JA et al. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 1994; 79:1267-76.
87. Rice J, Doggett B, Sweetser DA et al. Transgenic rescue of aganglionosis and piebaldism in lethal spotted mice. Dev Dyn 2000; 217:120-32.
88. Kusafuka T, Wang Y, Puri P. Mutation analysis of the RET, the endothelin-B receptor, and the endothelin-3 genes in sporadic cases of Hirschsprung’s disease. J Pediatr Surg 1997; 32:501-4.
89. Kusafuka T, Wang Y, Puri P. Novel mutations of the endothelin-B receptor gene in isolated patients with Hirschsprung’s disease. Hum Mol Genet 1996; 5:347-9.
90. Kusafuka T, Puri P. Mutations of the endothelin-B receptor and endothelin-3 genes in Hirschsprung’s disease. Pediatr Surg Int 1997; 12:19-23.
91. Bidaut C, Pelet A, Van Camp G et al. Endothelin-3 gene in isolated and syndromic Hirschsprung’s disease. Eur J Hum Genet 1997; 5:247-51.
92. Amiel J, Attie T, Jan D et al. Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung’s. Hum Mol Genet 1996; 5:355-7.
93. Oue T, Puri P. Altered endothelin-3 and endothelin-B receptor mRNA expression in Hirschsprung’s disease. J Pediatr Surg 1999; 34:1257-60.
94. Abe Y, Sakurai T, Yamada T et al. Functional analysis of five endothelin-B receptor mutations found in human Hirschsprung’s disease patients. Biochem Biophys Res Commun 2000; 275:524-31.
95. Puliti A, Cinti R, Betsos N et al. HOX11L1, a gene involved in peripheral nervous system development, maps to human chromosome 2p12-p13.1 and mouse chromosome 6C3-D1. Cytogenet Cell Genet 1999; 84:115-17.
96. Hatano M, Aoki T, Dezawa M et al. A novel pathogenesis of megacolon in Ncx/Hox11L1 deficient mice. J Clin Invest 1997; 100:795-801.
97. Shirasawa S, Yunker AMR, Roth KA et al. Enx (Hox11L1)-deficient mice develop myenteric neuronal hyperplasia and megacolon. Nat Med 1997; 3:646-50.
98. Puri P, Wester T. Intestinal neuronal dysplasia. Semin Pediatr Surg 1998; 7:181-6.
99. Southard-Smith EM, Kos L, Pavan WJ. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 1998; 18:60-4.
100. Kuhlbrodt K, Herbarth B, Sock E et al. Sox10, a novel transcriptional modulator in glial cells. J Neurosci 1998; 18:237-50.
101. Pingault V, Bondurand N, Kuhlbrodt K et al. SOX 10 mutations in patients with Waardenburg-Hirschsprung’s disease. Nat Genet 1998; 18:171-3.
102. Kuhlbrodt M, Schmidt C, Sock E et al. Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung’s disease. J Biochem 1998; 273:23033-8.
103. Hofstra RMW, Valdenarie O, Arch E et al. A loss of function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung’s disease, cardiac defects and autonomic disjunction. Am J Hum Genet 1999; 64:304-8.
104. Yanagisawa H, Yanagisawa M, Kapur RP et al. Dual genetic pathways of endothelin-mediated intercellular signalling revealed by targeted disruption of endothelin convertin enzyme-1 gene. Development 1998; 125:825-36.
105. Ehrenpreis T. Some newer aspects of Hirschsprung’s disease and allied disorders. J Pediatr Surg 1996; 1:329.
106. Bennett A, Garrett JR, Howard ER. Adrenergic myenteric nerves in Hirschsprung’s disease. Br Med J 1968; 1:487.
107. Gannon BJ, Noblett HR, Burnstock G. Adrenergic innervation of bowel in Hirschsprung’s disease. Br Med J 1969; 3:338.
108. Touloukian RJ, Aghajanian G, Roth RH. Adrenergic hyperactivity of the aganglionic colon. J Pediatr Surg 1983; 8:191.
109. Baumgarten HG, Holstein AG, Stelzner F. Nervous elements in the human colon of Hirschsprung’s disease. Virchows Arch 1973; 358:113.
110. Touloukian RJ, Morgenroth VH, Roth RH. Sympathetic neurotransmitter metabolism in Hirschsprung’s disease. J Pediatr Surg 1975; 10:593.
111. Kamijo K, Hiatt RB, Koelle B. Congenital megacolon: a comparison of the spastic and hypertrophic segments with respect to cholinesterase activities and sensitivities to acetylcholine, DFP and barium ion. Gastroenterology 1953; 24:173.
112. Meier-Ruge W. Das Megacolon: Seine Diagnose and Pathophysiologie. Virchows Arch 1968; 344:67.
113. Frigo GM, Del Tacca M, Lecchini S et al. Some observations on the intrinsic nervous mechanism in Hirschsprung’s disease. Gut 1973; 14:35.
114. Vizi ES, Zseli J, Kontor E et al. Characteristics of cholinergic neuroeffector transmission of ganglionic and aganglionic colon in Hirschsprung’s disease. Gut 1990; 31:1046.
115. Meier-Ruge W, Lutterbeck PM, Herzog B et al. Acetylcholinesterase activity in suction rectal biopsies of the rectum in the diagnosis of Hirschsprung’s disease. J Pediatr Surg 1972; 7:11.
116. Lake BD, Puri P, Nixon HH et al. Hirschsprung’s disease: an appraisal of histochemically demonstrated acetylcholine estrase in suction rectal biopsy specimens as an aid to diagnosis. Arch Pathol Lab Med 1978; 102:244.
117. Polak JM, Path MRC, Bloom SR. Neuropeptides of the gut: a newly discovered major control system. World J Surg 1979; 3:393.
118. Bishop AE, Polak JM, Lake BD et al. Abnormality ofthe colonic regulatory peptides in Hirschsprung’s disease. Histopathology 1981; 5:679.
119. Larsson LT, Malmfors G, Sundler F. Neuropeptide Y, calcitonin generelated peptide, and galanin in Hirschsprung’s disease: an immunocytochemical study. J Pediatr Surg 1988; 23:342.
120. Hamada Y, Bishop AE, Federici G. Increased neuropeptide Y-immunoreactive innervation of aganglionic bowel in Hirschsprung’s disease. Virchows Arch A 1987; 411:369.
121. Kawana T, Nada O, Hirose R. et al. Distribution of neuropeptide Y-like immunoreactivity in the normo-ganglionic and aganglionic segments of human colon. Acta Neuropathol 1990; 80:469.
122. Gabella G. Glial cells in the myenteric plexus. Z Naturforsch 1971; 266:244.
123. Gabella G. Ultrastructure ofthe nerve plexuses ofthe mammalian intestine: the enteric glaial cells. Neuroscience 1981; 6:425.
124. Jessen KR, Mirsky R. Glial cells in the enteric nervous system contain glial fibrillary acidic protein. Nature 1980; 286:736.
125. Eng LF. The glial fibrillary acidic (GFA) protein. In: Bradshaw R, Schneider D, editors. Proteins of the Nervous System. New York: Raven, 1980:85.
126. Ferri GL, Probert L, Cocchia D et al. Evidence for the presence of S-100 protein in the glial component ofthe human enteric nervous system. Nature 1982; 297:409.
127. Muller CM. Astrocytes in cat visual cortex studied by GFAP and S-100 immunocytochemistry during postnatal development. J Comp Neurol 1992; 317:309.
128. 7 monoclonal antibody. J Pediatr Surg 1987; 22:246.
129. 7. Biochem Soc Trans 1987; 15:279.
130. Taguchi T, Tanaka K, Ikeda K. Immunohistochemical study of neuron specific enolase and S-100 protein in the Hirschsprung’s disease. Virchows Arch 1985; 405:399.
131. Kato H, Yamamoto T, Yamamoto H et al. Immunocytochemical characterization of supporting cells in the enteric nervous system in Hirschsprung’s disease. J Pediatr Surg 1990; 25:514.
132. 7 monoclonal antibody. J Pediatr Surg 1987; 22:246.
133. Vanderwinden JM, De Leat MH, Schiffmann SN et al. Nitric oxide synthase distribution in the enteric nervous system of Hirschsprung’s disease. Gastroenterology 1993; 105:969-73.
134. Kobayashi H, O’Briain S, Puri P. Lack of expression of NADPH-diaphorase and neural cell adhesion molecule (NCAM) in colonic muscle of patient with Hirschsprung’s disease. J Pediatr Surg 1994; 29:301-4.
135. Bealer JF, Natuzzi ES, Buscher C et al. Nitric oxide synthase distribution is deficient in the aganglionic colon of patients with Hirschsprung’s disease. Pediatrics 1994; 93:647-51.
136. Larsson LT, Shen Z, Ekblad E et al. Lack of neuronal nitric oxide synthase in nerve fibres of aganglionic intestine: A clue to Hirschsprung’s disease. J Pediatr Gastroenterol Nutr 1995; 20:49-53.
137. Guo R, Nada O, Suita S et al. The distribution and colocalization of nitric oxide synthase and vasoactive intestinal polypeptide in nerves of the colons with Hirschsprung’s disease. Virchows Arch 1997; 430:53-61.
138. Kusafuka T, Puri P. Altered mRNA expression of neuronal nitric oxide synthase gene in Hirschsprung’s disease. J Pediatr Surg 1997; 32:1054-8.
139. Nemeth L, Puri P. Three-dimensional morphology of c-Kit positive cellular network and nitrergic innervation. Arch Pathol Lab Med 2001; 125:899-904.
140. Wu JJ, Rothman TP, Gershon MD. Development of the interstitial cell of Cajal: Origin, kit dependence and neuronal and nonneuronal sources of kit ligand. J Neurosc Res 2000; 59:384-401.
141. Vanderwinden JM, Lui H, De Laet MH, Vanderhaeghen JJ. Study of the interstitial cells of Cajal in infantile hypertrophic pyloric stenosis. Gastroenterol 1996; 111:279-88.
142. Vanderwinden JM, Rumessen JJ, Lui H, Descamps D, De Laet MH, Vanderhaegen JJ. Interstitial cells of Cajal in human colon and in Hirschsprung’s disease. Gastroenterol 1996; 111:901-10.
143. Yamataka A, Ohshiro K, Kobayashi H, Fujiwara T, Sunagawa M, Miyano T. Intestinal pacemaker C-KIT + cells and synapses in allied Hirschsprung’s disorders. J Pediatr Surg 1997; 32:1069-74.
144. Yamataka A, Kato Y, Tibboel D et al. A lack of intestinal pacemaker (c-kit) in aganglionic bowel of patients with Hirschsprung’s disease. J Pediatr Surg 1995; 30:441-4.
145. Rolle U, Piotrowska AP, Nemeth L, Puri P. Altered distribution of interstitial cells of Cajal in Hirschsprung’s disease. Arch Pathol Lab Med (in press).
146. Yamataka A, Ohshiro K, Kobayashi H et al. Abnormal distribution of intestinal pacemaker (C-Kit-positive) cells in an infant with chronic idiopathic intestinal pseudoobstruction. J Pediatr Surg 1998; 33:859-62.
147. Isozaki K, Hirota S, Miyagawa J, Taniguchi M, Shinomura Y, Matsuzawa Y. Deficiency of c-kit+ cells in patients with a myopathic form of chronic idiopathic intestinal pseudo-obstruction. Am J Gastroenterol 1997; 92:332-4.
148. Kenny SE, Vanderwinden JM, Rintala RJ et al. Delayed maturatin of the interstitial cells of Cajal: a new diagnosis for transient neonatal pseudoobstruction. J Pediatr Surg 1998; 33:94-8.
149. He CL, Burgart L, Wang L, Pemberton J, Young-Fadok T, Szurszewski J, Farrugia G. Decreased interstitial cell of Cajal volume in patients with slow-transit disease. Gastroenterology 2000; 118:12-21.
150. Rumessen JJ. Ultrastructure of interstitial cells of Cajal at the colonic submuscular border in patients with ulcerative colitis. Gastroenterology 1996; 111:1447-55.
151. Horisawa M, Watanabe Y, Torihashi S. Distribution of c-Kit immunopositive cells in normal human colon and in Hirschsprung’s disease. J Pediatr Surg 1998; 33:1209-14.
152. Puri P. Hirschsprung’s disease. In: Holschneider AM, Puri P, editors. Clinical Generalities in Hirschsprung’s Disease and Allied Disorders.Singapore: Harwood Academic Publishers, 2000:129-36.
153. Puri P, Wester T. Enterocolitis complicating Hirschsprung’s disease. In: Holschneider AM, Puri, P, editors. Hirschsprung’s Disease and Allied Disorders. Singapore: Harwood Academic Publishers, 2000:165-74.
154. Gowers WR. The automatic action of the sphincter ani. Proc Roy Soc Med 1877; 26:77-84.
155. Callaghan RP, Nixon HH. Megarectrum: physiological observations. Arch Dis Childh 1964; 39:153-7.
156. Lawson JON, Nixon HH. Anal cam pressures in the diagnosis of Hirschsprung’s disease. J Pediatr Surg 1967; 2:544-52.
157. Schnaufer L, Talbert JL, Haller JA. Differential sphincteric studies in the diagnosis of anorectal disorders of childhood. J Pediatr Surg 1967; 2:538-43.
158. Aaronson IA, Nixon HH. A clinical evaluation of anorectal pressure studies in the diagnosis of Hirschsprung’s disease. Gut 1972; 13:138.
159. Loening-Baucke VA. Anorectal manometry: experience with strain gauge pressure transducers for the diagnosis of Hirschsprung’s disease. J Pediatr Surg 1983; 18:595-600.
160. Sun WM, Read NW, Prior A et al. Sensory and motor responses to rectal distension vary according to rate and pattern of balloon inflation. Gastroneterol 1990; 99:1008-15.
161. Iwai N, Yanagihara J, Tokiwa K et al. Reliability of anorectal manometry in the diagnosis of Hirschsprung’s disease. Z Kinderchis 1998; 43:405-7.
162. Holschneider AM. Functional diagnosis in Hirschsprung’s disease. In: Holschneider AM, Puri P. Hirschsprung’s Disease and Allied Disorders. Singapore: Harwood Publishers, 2000:230-51.
163. Holschneider AM, Kellner E, Streibl P et al. The development of anorectal continence and its significance in the diagnosis of Hirschsprung’s disease. J Pediatr Surg 1976; 11:151-6.
164. Ito Y, Donahoe PK, Hendren WH. Maturation of the rectoanal response in premature and perinatal infants. J Pediatr Surg 1977; 12:477-82.
165. Smith B. Pre and postnatal development of ganglion cells of the rectum and its surgical implications. J Pediatr Surg 1968; 3:386-92.
166. Bughaighis AG, Emery JL. Functional obstruction of the intestine due to neurological immaturity. Progr Pediatr Surg 1971; 3:37-52.
167. Puri P, Blake N, Carroll R et al. Relationship between functional and histologic appearances of developing ganglion cells in the guinea pig rectum. J Pediatr Surg 1980; 15:42-7.
168. Boston VE, Scott JES. anorectal manometry as a diagnostic method in the neonatal period. J Pediatr Surg 1976; 1:9-16.
169. Loening-Baucke V, Pringle KC, Ekiro GG. Anorectal manometry for the exclusion of Hirschsprung’s disease in neonates. J Pediatr Gastroenterol Nutr 1985; 4:596-603.
170. Tamate S, Shiokawa C, Yamada C et al. Manometric diagnosis of Hirschsprung’s disease in the neonatal period. J Pediatr Surg 1984; 19:285-8.
171. Verder H, Peterson W, Mauritzen K. Anal tonometry in the neonatal period for the diagnosis of Hirschsprung’s disease. Acta Paediatr Scand 1991; 80:45-50.
172. Nunez R, Vargas I, Rubio I et al. Anorectal manometry in newborns. Pediatr Surg Int 1995; 10:105-7.
173. Meier-Ruge W, Lutterbeck PM, Herzog B et al. Acetylcholinesterase activity in suction rectal biopsies of the rectum in the diagnosis of Hirschsprung’s disease. J Pediatr Surg 1972; 7:11-17.
174. Lake BD, Puri P, Nixon HH et al. Hirschsprung’s disease. An appraisal of histochemically demonstrated acetylcholine esterase in suction rectal biopsy specimens as an aid to diagnosis. Arch Path Lab Med 1978; 102:244-7.
175. Lake BD, Malone MT, Risdon RA. Acetylcholinesterase in the diagnosis of Hirschsprung’s disease, including a comment on intestinal neuronal dysplasia. Pediatr Pathol 1989; 9:351-4.
176. Schofield DE, Devine W, Yunis EJ. Acetylcholinesterase stained suction rectal biopsies in the diagnosis of Hirschsprung’s disease. J Pediatr Gastroenterol Nutr 1990; 11:221-8.
177. Athon AC, Filipe MI, Drake DP. Problems and advantages of acetycholinestrase histochemistry of rectal suction biopsies in the diagnosis of Hirschsprung’s disease. J Pediatr Surg 1990; 25:520-6.
178. Kobayashi H, O’Briain DS, Hirakawa H, Wang Y, Puri P. A rapid technique of acetycholinestrase staining. Arch Pathol Lab Med 1994; 118:1127-9.
179. Kobayashi H, Wang Y, Hirakawa H, O’Briain D-S, Puri P. Intraoperative evaluation of the extent of aganglionosis by a rapid of acetylcholinesterase histochemistry. J Pediatr Surg 1995; 30:248-52.
180. Miyazaki E, Ohshiro K, Puri P. NADPH-diaphorase histochemical staining of suction rectal biopsies in the diagnosis of Hirschsprung’s disease and allied disorders. Pediatr Surg Int 1998; 13:464-7.
181. Thomas DFM, Fernie DS, Bayston R et al. Enterocolitis in Hirschsprung’s disease: a controlled study of the etiologic role of Clostridium difficile. J Pediatr Surg 1986; 21:22-5.
182. So HB, Schwartz DL, Becker JM et al. Endorectal ‘pull-through’ without preliminary colostomy in neonates with Hirschsprung’s disease. J Pediatr Surg 1980; 15:470-1.
183. Carcassonne M, Guys J.M, Morrison-Lacombe G et al. Management of Hirschsprung’s disease: curative surgery before three months of age. J Pediatr Surg 1989; 24:1032-4.
184. Cass DT. Neonatal one-stage repair of Hirschsprung’s disease. Pediatr Surg Int 1990; 5:341-6.
185. Cilley RE, Statter MB, Hirschl RB et al. Definitive treatment of Hirschsprung’s disease in the newborn with a one-stage procedure. Surgery 1994; 115:551-6.
186. Wilcox DT, Bruce J, Bowen J et al. One-stage neonatal pull-through to treat Hirschsprung’s disease. J Pediatr Surg 1997; 32:243-5.
187. Coran AG, Teitelbaum DH. Recent advances in the management of Hirschsprung’s disease. Am J Surg 2000; 180:382-7.
188. Georgeson KE, Fuenfer MM, Hardin WD. Primary laparoscopic pull-through for Hirschsprung’s disease in infants and children. J Pediatr Surg 1995; 30:1017-21.
189. De Lagausie P, Berrebi D, Geib G, Sebag G, Aigrain Y. Laparoscopic Duhamel procedure. Management of 30 cases. Surg Endosc 1999; 13:972-4.
190. Georgeson KE, Cohen RD, Hebra A, Jona JZ, Powell DM, Rothenberg SS, Tagge EP. Primary laparoscopic-assisted endorectal colon pull-through for Hirschsprung’s disease: a new gold standard. Ann Surg 1999; 229:678-82.
191. De La Torre-Mondragon L, Ortega-Salgado JA. Transanal endorectal pull-through for Hirschsprung’s disease. J Pediatr Surg 1998; 33:1283-6.
192. Langer JC, Minkes RK, Mazziotti MV, Skinner MA, Winthroop AL. Transanal One-Stage Soave Procedure for Infants With Hirschsprung’s Disease. J Pediatr Surg 1999; 34:148-52.
193. Swenson O, Bill AH. Resection of rectum and rectosigmoid with preservation of sphincter for benign spastic lesions producing megacolon. Surgery 1948; 24:212-20.
194. Duhamel B. A new operation for the treatment of Hirschsprung’s disease. Arch Dis Child 1960; 35:38-9.
195. Soave F. Hirschsprung’s disease. A new surgical technique. Arch Dis Childh 1964; 39:116-24.
196. Teitelbaum DH, Coran AG. Longterm results and quality of life after treatment of Hirschsprung’s disease and allied disorders. In: Holschneider AM, Puri P, editors. Hirschsprung’s disease and allied disorders. Singapore: Harwood Publishers, 2000:457-66.